Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
Anticancer Res
    September 2017
  1. CICERO G, Lo Re G, DE Luca R, Vernuccio F, et al
    Role of Densitometric Criteria in Evaluation of Effectiveness of Antiangiogenic Therapies in Metastatic Colorectal Cancer: An Italian Clinical Experience.
    Anticancer Res. 2017;37:5187-5192.
    >> Share

  2. NEKI K, Eto K, Kosuge M, Ohkuma M, et al
    Comparison of Postoperative Outcomes Between Laparoscopic and Open Surgery for Colorectal Cancer.
    Anticancer Res. 2017;37:5173-5177.
    >> Share

  3. LI A, Kasmann L, Rades D, Fu C, et al
    A Scoring System to Predict the Development of Bone Metastasis After Radical Resection of Colorectal Cancer.
    Anticancer Res. 2017;37:5169-5172.
    >> Share

  4. LEE JH, Yoon YM, Lee SH
    GRP78 Regulates Apoptosis, Cell Survival and Proliferation in 5-Fluorouracil-resistant SNUC5 Colon Cancer Cells.
    Anticancer Res. 2017;37:4943-4951.
    >> Share

  5. DIVELLA R, Daniele A, DE Luca R, Simone M, et al
    Circulating Levels of VEGF and CXCL1 Are Predictive of Metastatic Organotropismin in Patients with Colorectal Cancer.
    Anticancer Res. 2017;37:4867-4871.
    >> Share

  6. SATO T, Higuchi Y, Shibagaki Y, Hattori S, et al
    Phosphoproteomic Analysis Identifies Signaling Pathways Regulated by Curcumin in Human Colon Cancer Cells.
    Anticancer Res. 2017;37:4789-4798.
    >> Share

  7. GU D, Szallasi A
    Thrombocytosis Portends Adverse Prognosis in Colorectal Cancer: A Meta-Analysis of 5,619 Patients in 16 Individual Studies.
    Anticancer Res. 2017;37:4717-4726.
    >> Share

    August 2017
  8. YANG Y, Li J, Jin L, Wang D, et al
    Independent Correlation Between Ki67 Index and Circulating Tumor Cells in the Diagnosis of Colorectal Cancer.
    Anticancer Res. 2017;37:4693-4700.
    >> Share

  9. CHEN J, DU F, Hu B, Chi C, et al
    Severe Cardiotoxicity in a Patient with Colorectal Cancer Treated with Bevacizumab.
    Anticancer Res. 2017;37:4557-4561.
    >> Share

  10. ZHENG F, Zhang Z, Flamini V, Jiang WG, et al
    The Axis of CXCR4/SDF-1 Plays a Role in Colon Cancer Cell Adhesion Through Regulation of the AKT and IGF1R Signalling Pathways.
    Anticancer Res. 2017;37:4361-4369.
    >> Share

  11. LONG ZH, Bai ZG, Song JN, Zheng Z, et al
    miR-141 Inhibits Proliferation and Migration of Colorectal Cancer SW480 Cells.
    Anticancer Res. 2017;37:4345-4352.
    >> Share

  12. ARIMOTO A, Hasegawa H, Sugiyama H, Yamashita K, et al
    Safety and Effectiveness of Laparoscopic Colorectal Resection in Elderly Patients with Colorectal Cancer: A Propensity Score Matching Study.
    Anticancer Res. 2017;37:4195-4198.
    >> Share

  13. SHIBUTANI M, Maeda K, Nagahara H, Fukuoka T, et al
    The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1+ to CD8+ Lymphocyte Ratio in Patients with Colorectal Cancer.
    Anticancer Res. 2017;37:4165-4172.
    >> Share

  14. URUSHIBARA S, Tsubota T, Asai R, Azumi J, et al
    WNT/beta-Catenin Signaling Inhibitor IC-2 Suppresses Sphere Formation and Sensitizes Colorectal Cancer Cells to 5-Fluorouracil.
    Anticancer Res. 2017;37:4085-4091.
    >> Share

  15. YAO HW, Wu GC, Yang YC, Jin L, et al
    Laparoscopic-assisted Transanal Total Mesorectal Excision for Middle-Low Rectal Carcinoma: A Clinical Study of 19 Cases.
    Anticancer Res. 2017;37:4599-4604.
    >> Share

    July 2017
  16. YOSHIDA Y, Naito M, Yamada T, Aisu N, et al
    Clinical Study on the Medical Value of Combination Therapy Involving Adoptive Immunotherapy and Chemotherapy for Stage IV Colorectal Cancer (COMVI Study).
    Anticancer Res. 2017;37:3941-3946.
    >> Share

  17. ISHII F, Yoshida Y, Yamauchi Y, Aisu N, et al
    Hepatectomy for Liver Metastases of Colorectal Cancer After Adoptive Chemoimmunotherapy Using Activated alphabeta T-cells.
    Anticancer Res. 2017;37:3933-3939.
    >> Share

  18. NISHI K, Luo H, Nakabayashi K, Doi K, et al
    An Alpha-kinase 2 Gene Variant Disrupts Filamentous Actin Localization in the Surface Cells of Colorectal Cancer Spheroids.
    Anticancer Res. 2017;37:3855-3862.
    >> Share

  19. NISHI K, Luo H, Ishikura S, Doi K, et al
    Apremilast Induces Apoptosis of Human Colorectal Cancer Cells with Mutant KRAS.
    Anticancer Res. 2017;37:3833-3839.
    >> Share

  20. WEIN A, Siebler J, Wolff K, Ostermeier N, et al
    Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC).
    Anticancer Res. 2017;37:3771-3779.
    >> Share

  21. GREENE C, Nakakura EK, Ko AH
    Gastrocutaneous Fistula in a Patient with Locally Recurrent MSI-High Colorectal Cancer: Local Complications Arising from Therapeutic Response to Immune Checkpoint Blockade.
    Anticancer Res. 2017;37:3679-3684.
    >> Share

  22. KINUGASA T, Mizobe T, Shiraiwa S, Akagi Y, et al
    Perineural Invasion Is a Prognostic Factor and Treatment Indicator in Patients with Rectal Cancer Undergoing Curative Surgery: 2000-2011 Data from a Single-center Study.
    Anticancer Res. 2017;37:3961-3968.
    >> Share

  23. TAJIRI K, Sudou T, Fujita F, Hisaka T, et al
    Clinicopathological and Corresponding Genetic Features of Colorectal Signet Ring Cell Carcinoma.
    Anticancer Res. 2017;37:3817-3823.
    >> Share

  24. BRUNS-TOEPLER M, Hardt P
    Evaluation of a New Technique for iFOBT Utilising a New Sample Collection Device with Increased Buffer Stability.
    Anticancer Res. 2017;37:3735-3740.
    >> Share

  25. CHAO C, Widen SG, Wood TG, Zatarain JR, et al
    Patient-derived Xenografts from Colorectal Carcinoma: A Temporal and Hierarchical Study of Murine Stromal Cell Replacement.
    Anticancer Res. 2017;37:3405-3412.
    >> Share

  26. DE MARCHIS ML, Tonelli F, Quaresmini D, Lovero D, et al
    Desmoid Tumors in Familial Adenomatous Polyposis.
    Anticancer Res. 2017;37:3357-3366.
    >> Share

    June 2017
  27. GOGENUR M, Hillig T, Gogenur I
    CytoTrack Analysis Reveals Low Presence of Circulating Tumor Cells in the Perioperative Period in Patients with Non-metastatic Colorectal Cancer.
    Anticancer Res. 2017;37:3099-3103.
    >> Share

  28. YUN S, Han YS, Lee JH, Kim S, et al
    Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
    Anticancer Res. 2017;37:2975-2984.
    >> Share

  29. JEONG KY, Park M, Kim IU, Sim JJ, et al
    Enhancing 5-Fluorouracil Efficacy in a Primary Colorectal Cancer by Long-lasting Calcium Supplementation.
    Anticancer Res. 2017;37:2959-2964.
    >> Share

  30. GONG J, Chen Y, Yang L, Pillai R, et al
    MEK162 Enhances Antitumor Activity of 5-Fluorouracil and Trifluridine in KRAS-mutated Human Colorectal Cancer Cell Lines.
    Anticancer Res. 2017;37:2831-2838.
    >> Share

  31. BADAKHSHI H, Ismail M, Boskos C, Zhao K, et al
    The Role of Concomitant Radiation Boost in Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Anticancer Res. 2017;37:3201-3205.
    >> Share

  32. PINSK V, Pinsk I, Ling G, Yerushalmi B, et al
    Complete Reversion of Familial Adenomatous Polyposis Phenotype Associated with Tacrolimus and Mycophenolate Mofetil Treatment Following Kidney Transplantation.
    Anticancer Res. 2017;37:3105-3109.
    >> Share

    May 2017
  33. JINGU K, Matsuo Y, Onishi H, Yamamoto T, et al
    Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer.
    Anticancer Res. 2017;37:2709-2713.
    >> Share

  34. JI WB, Um JW, Ryu JS, Hong KD, et al
    Clinical Significance of 5-Fluorouracil Chemosensitivity Testing in Patients with Colorectal Cancer.
    Anticancer Res. 2017;37:2679-2682.
    >> Share

  35. IRABOR DO, Oluwasola OA, Ogunbiyi OJ, Ogun OG, et al
    Microsatellite Instability Is Common in Colorectal Cancer in Native Nigerians.
    Anticancer Res. 2017;37:2649-2654.
    >> Share

  36. SASAKI S, Ueda M, Iguchi T, Kaneko M, et al
    DDR2 Expression Is Associated with a High Frequency of Peritoneal Dissemination and Poor Prognosis in Colorectal Cancer.
    Anticancer Res. 2017;37:2587-2591.
    >> Share

  37. DRESSEN K, Hermann N, Manekeller S, Walgenbach-Bruenagel G, et al
    Diagnostic Performance of a Novel Multiplex Immunoassay in Colorectal Cancer.
    Anticancer Res. 2017;37:2477-2486.
    >> Share

  38. GOMBODORJ N, Yokobori T, Yoshiyama S, Kawabata-Iwakawa R, et al
    Inhibition of Ubiquitin-conjugating Enzyme E2 May Activate the Degradation of Hypoxia-inducible Factors and, thus, Overcome Cellular Resistance to Radiation in Colorectal Cancer.
    Anticancer Res. 2017;37:2425-2436.
    >> Share

  39. SATO K, Masuda T, Hu Q, Tobo T, et al
    Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer.
    Anticancer Res. 2017;37:2365-2371.
    >> Share

  40. YUEH TC, Chou AK, Gong CL, Fu CK, et al
    The Contribution of Excision Repair Cross-complementing Group 1 Genotypes to Colorectal Cancer Susceptibility in Taiwan.
    Anticancer Res. 2017;37:2307-2313.
    >> Share

  41. UEDA M, Iguchi T, Masuda T, Komatsu H, et al
    Up-regulation of SLC9A9 Promotes Cancer Progression and Is Involved in Poor Prognosis in Colorectal Cancer.
    Anticancer Res. 2017;37:2255-2263.
    >> Share

  42. BARABINO M, Gatti A, Santambrogio R, Polizzi M, et al
    Intraoperative Local Ablative Therapies Combined with Surgery for the Treatment of Bilobar Colorectal Liver Metastases.
    Anticancer Res. 2017;37:2743-2750.
    >> Share

  43. EISTERER W, Piringer G, DE Vries A, Ofner D, et al
    Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
    Anticancer Res. 2017;37:2683-2691.
    >> Share

  44. BACALBASA N, Balescu I
    Infracolic Approach to the Superior Mesenteric Vessels for a Large Pancreatic Tumor with Right Colon Invasion - A Case Report and Literature Review.
    Anticancer Res. 2017;37:2609-2613.
    >> Share

  45. BACALBASA N, Stoica C, Balescu I
    Multiple Visceral Resections for Synchronous Left and Transverse Colon Adenocarcinoma with Gastrocolic-cutaneous Fistula - Case Report and Literature Review.
    Anticancer Res. 2017;37:2601-2607.
    >> Share

  46. NUMATA M, Yamaguchi T, Kinugasa Y, Shiomi A, et al
    Index of Estimated Benefit from Lateral Lymph Node Dissection for Middle and Lower Rectal Cancer.
    Anticancer Res. 2017;37:2549-2555.
    >> Share

  47. RUBIO CA
    Are Corrupted Non-dysplastic Colonic Crypts the First Histological Event in Experimental Colonic Carcinogenesis?
    Anticancer Res. 2017;37:2265-2268.
    >> Share

    April 2017
  48. STOTZ M, Herzog SA, Pichler M, Smolle M, et al
    Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
    Anticancer Res. 2017;37:2011-2018.
    >> Share

  49. BASSO SM, Lumachi F, Pianon P, Fanti G, et al
    Analysis of Factors Affecting Short-term Results in Elderly Patients Undergoing Elective Surgical Resection for Stage I-II Colon Cancer.
    Anticancer Res. 2017;37:1971-1974.
    >> Share

  50. BUNDSCHERER AC, Malsy M, Bitzinger DI, Wiese CH, et al
    Effects of Lidocaine on HT-29 and SW480 Colon Cancer Cells In Vitro.
    Anticancer Res. 2017;37:1941-1945.
    >> Share

  51. SKERENOVA M, Halasova E, Matakova T, Jesenska L, et al
    Low Variability and Stable Frequency of Common Haplotypes of the TP53 Gene Region in Colorectal Cancer Patients in a Slovak Population.
    Anticancer Res. 2017;37:1901-1907.
    >> Share

  52. FORSBERG A, Keranen A, VON Holst S, Picelli S, et al
    Defining New Colorectal Cancer Syndromes in a Population-based Cohort of the Disease.
    Anticancer Res. 2017;37:1831-1835.
    >> Share

  53. JANG HH, Lee HN, Kim SY, Hong S, et al
    Expression of RNA-binding Motif Protein 3 (RBM3) and Cold-inducible RNA-binding protein (CIRP) Is Associated with Improved Clinical Outcome in Patients with Colon Cancer.
    Anticancer Res. 2017;37:1779-1785.
    >> Share

  54. PINTOVA S, Planutis K, Planutiene M, Holcombe RF, et al
    ME-143 Is Superior to Genistein in Suppression of WNT Signaling in Colon Cancer Cells.
    Anticancer Res. 2017;37:1647-1653.
    >> Share

  55. KOTAKE Y, Arikawa N, Tahara K, Maru H, et al
    Y-box Binding Protein 1 Is Involved in Regulating the G2/M Phase of the Cell Cycle.
    Anticancer Res. 2017;37:1603-1608.
    >> Share

  56. KINDLER C, Smedh K, Chabok A, Shetye J, et al
    Detection of Free Cancer Cells in Pelvic Lavage with Double Immunocytochemistry at Rectal Cancer Surgery.
    Anticancer Res. 2017;37:1563-1568.
    >> Share

  57. VOGL UM, Ohler L, Rasic M, Frischer JM, et al
    Evaluation of Prognostic Immune Signatures in Patients with Breast, Colorectal and Pancreatic Cancer Receiving Chemotherapy.
    Anticancer Res. 2017;37:1947-1955.
    >> Share

    March 2017
  58. FUJIKAWA H, Toiyama Y, Inoue Y, Imaoka H, et al
    Prognostic Impact of Preoperative Albumin-to-Globulin Ratio in Patients with Colon Cancer Undergoing Surgery with Curative Intent.
    Anticancer Res. 2017;37:1335-1342.
    >> Share

  59. YOON YS, Kim CW, Roh SA, Cho DH, et al
    Development and Applicability of Integrative Tumor Response Assays for Metastatic Colorectal Cancer.
    Anticancer Res. 2017;37:1297-1303.
    >> Share

  60. SEPAROVIC D, Shields AF, Philip PA, Bielawski J, et al
    Altered Levels of Serum Ceramide, Sphingosine and Sphingomyelin Are Associated with Colorectal Cancer: A Retrospective Pilot Study.
    Anticancer Res. 2017;37:1213-1218.
    >> Share

  61. TRESKA V, Fichtl J, Bruha J, Liska V, et al
    Liver Resections for Colorectal Metastases in Patients Aged Over 75 Years.
    Anticancer Res. 2017;37:1529-1533.
    >> Share

  62. WINDRICHOVA J, Fuchsova R, Kucera R, Topolcan O, et al
    MIC1/GDF15 as a Bone Metastatic Disease Biomarker.
    Anticancer Res. 2017;37:1501-1505.
    >> Share

  63. LEE IH, Hwang S, Lee SJ, Kang BW, et al
    Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
    Anticancer Res. 2017;37:1459-1465.
    >> Share

  64. ETO K, Kondo I, Kosuge M, Ohkuma M, et al
    Enhanced Recovery After Surgery Programs for Laparoscopic Colorectal Resection May Not Need Thoracic Epidural Analgesia.
    Anticancer Res. 2017;37:1359-1364.
    >> Share

  65. SIDERIS M, Moorhead J, Diaz-Cano S, Haji A, et al
    KRAS Mutant Status May Be Associated with Distant Recurrence in Early-stage Rectal Cancer.
    Anticancer Res. 2017;37:1349-1357.
    >> Share

  66. KUBO T, Hirohashi Y, Matsuo K, Sonoda T, et al
    Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative "Adaptive Immune Escape" Phenomenon.
    Anticancer Res. 2017;37:1289-1295.
    >> Share

  67. DANIELE A, Divella R, Abbate I, Casamassima A, et al
    Assessment of Nutritional and Inflammatory Status to Determine the Prevalence of Malnutrition in Patients Undergoing Surgery for Colorectal Carcinoma.
    Anticancer Res. 2017;37:1281-1287.
    >> Share

  68. LYBEROPOULOU A, Galanopoulos M, Aravantinos G, Theodoropoulos GE, et al
    Identification of Methylation Profiles of Cancer-related Genes in Circulating Tumor Cells Population.
    Anticancer Res. 2017;37:1105-1112.
    >> Share

  69. RUBIO CA
    The Histogenesis of the Third Pathway of Colonic Carcinogenesis in Rats.
    Anticancer Res. 2017;37:1039-1042.
    >> Share

  70. DOGAN A, Schultheis B, Rezniczek GA, Hilal Z, et al
    Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature.
    Anticancer Res. 2017;37:969-978.
    >> Share

    February 2017
  71. HA GS, Kim YW, Choi EH, Kim IY, et al
    Factors Associated with the Lack of Adjuvant Chemotherapy Following Curative Surgery for Stage II and III Colon Cancer: A Korean National Cohort Study.
    Anticancer Res. 2017;37:915-922.
    >> Share

  72. KANEKO M, Ishihara S, Murono K, Sasaki K, et al
    Carbohydrate Antigen 19-9 Predicts Synchronous Peritoneal Carcinomatosis in Patients with Colorectal Cancer.
    Anticancer Res. 2017;37:865-870.
    >> Share

  73. HAGLAND HR, Lea D, Watson MM, Soreide K, et al
    Correlation of Blood T-Cells to Intratumoural Density and Location of CD3+ and CD8+ T-Cells in Colorectal Cancer.
    Anticancer Res. 2017;37:675-683.
    >> Share

  74. IWATA N, Ishikawa T, Okazaki S, Mogushi K, et al
    Clinical Significance of Methylation and Reduced Expression of the Quaking Gene in Colorectal Cancer.
    Anticancer Res. 2017;37:489-498.
    >> Share

  75. CHUNG SS, Adekoya D, Enenmoh I, Clarke O, et al
    Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells.
    Anticancer Res. 2017;37:445-453.
    >> Share

  76. GALANOPOULOS M, Papanikolaou IS, Zografos E, Viazis N, et al
    Comparative Study of Mutations in Single Nucleotide Polymorphism Loci of KRAS and BRAF Genes in Patients Who Underwent Screening Colonoscopy, With and Without Premalignant Intestinal Polyps.
    Anticancer Res. 2017;37:651-657.
    >> Share

  77. LIBERALE G, Lecocq C, Garcia C, Muylle K, et al
    Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
    Anticancer Res. 2017;37:929-934.
    >> Share

    January 2017

  78. Non-coding RNAs in Colorectal Cancer.
    Anticancer Res. 2017;37:369.
    >> Share

  79. PASQUALETTI F, Montrone S, Vivaldi C, Zani M, et al
    Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer.
    Anticancer Res. 2017;37:315-319.
    >> Share

  80. FUJIYOSHI K, Yamamoto G, Takenoya T, Takahashi A, et al
    Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
    Anticancer Res. 2017;37:239-247.
    >> Share

  81. PARK M, Sundaramoorthy P, Sim JJ, Jeong KY, et al
    Synergistically Anti-metastatic Effect of 5-Flourouracil on Colorectal Cancer Cells via Calcium-mediated Focal Adhesion Kinase Proteolysis.
    Anticancer Res. 2017;37:103-114.
    >> Share

  82. IMAI T, Oue N, Sentani K, Sakamoto N, et al
    KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells.
    Anticancer Res. 2017;37:47-55.
    >> Share

  83. SANTOS MD, Silva C, Rocha A, Nogueira C, et al
    Prognostic and Therapeutic Potential Implications of Genetic Variability in Prostaglandin E2 Pathway Genes in Rectal Cancer.
    Anticancer Res. 2017;37:281-291.
    >> Share

  84. ATTENBERGER UI, Ong MM, Rathmann N, Doyon F, et al
    mMRI at 3.0 T as an Evaluation Tool of Therapeutic Response to Neoadjuvant CRT in Patients with Advanced-stage Rectal Cancer.
    Anticancer Res. 2017;37:215-222.
    >> Share

  85. RUBIO CA
    Three Pathways of Colonic Carcinogenesis in Rats.
    Anticancer Res. 2017;37:15-20.
    >> Share

  86. MORIS D, Dimitroulis D, Vernadakis S, Papalampros A, et al
    Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes.
    Anticancer Res. 2017;37:9-14.
    >> Share

    December 2016
  87. SUZUKI A, Kobayashi R, Fujii H, Iihara H, et al
    Control of Nausea and Vomiting in Patients with Colorectal Cancer Receiving Chemotherapy with Moderate Emetic Risk.
    Anticancer Res. 2016;36:6527-6533.
    >> Share

  88. NAGANO Y, Toiyama Y, Okugawa Y, Imaoka H, et al
    MicroRNA-7 Is Associated with Malignant Potential and Poor Prognosis in Human Colorectal Cancer.
    Anticancer Res. 2016;36:6521-6526.
    >> Share

  89. YEO MK, Lee YM, Seong IO, Choi SY, et al
    Up-regulation of Cytoplasmic CD24 Expression Is Associated with Malignant Transformation but Favorable Prognosis of Colorectal Adenocarcinoma.
    Anticancer Res. 2016;36:6593-6598.
    >> Share

  90. SHANY S, Sigal-Batikoff I, Lamprecht S
    Vitamin D and Myofibroblasts in Fibrosis and Cancer: At Cross-purposes with TGF-beta/SMAD Signaling.
    Anticancer Res. 2016;36:6225-6234.
    >> Share

    November 2016
  91. ICHIHARA H, Okumura M, Matsumoto Y
    Therapeutic Effects of Hybrid Liposomes Against Xenograft Mouse Model of Colorectal Cancer In Vivo Due to Long-term Accumulation.
    Anticancer Res. 2016;36:5875-5882.
    >> Share

  92. CHIEN CR, Chen WT, Wang HM, Ke TW, et al
    A Comparative Effectiveness Study of Two Oral Chemotherapy Drugs (UFT vs. Capecitabine) in Neoadjuvant Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.
    Anticancer Res. 2016;36:6155-6160.
    >> Share

    October 2016
  93. ALT M, Truant S, Renaud-Vantroys T, Sequier C, et al
    Bevacizumab Associated with Chemotherapy for Initially Non-resectable Liver Metastases from Colorectal Cancer: a Case-Control Study.
    Anticancer Res. 2016;36:5551-5555.
    >> Share

  94. SARLINOVA M, Halasa M, Mistuna D, Musak L, et al
    miR-21, miR-221 and miR-150 Are Deregulated in Peripheral Blood of Patients with Colorectal Cancer.
    Anticancer Res. 2016;36:5449-5454.
    >> Share

  95. YAMAOKA Y, Ikeda M, Ikenaga M, Murakami H, et al
    Anti-metastatic Effect of Short-term Postoperative Anticoagulation for Patients Undergoing Curative Resection of Colorectal Cancer.
    Anticancer Res. 2016;36:5425-5429.
    >> Share

  96. KODA K, Miyauchi H, Kosugi C, Kaiho T, et al
    Tumor 5-FU-related mRNA Expression and Efficacy of Oral Fluoropyrimidines in Adjuvant Chemotherapy of Colorectal Cancer.
    Anticancer Res. 2016;36:5325-5331.
    >> Share

  97. ALFAYEZ M, Vishnubalaji R, Alajez NM
    Runt-related Transcription Factor 1 (RUNX1T1) Suppresses Colorectal Cancer Cells Through Regulation of Cell Proliferation and Chemotherapeutic Drug Resistance.
    Anticancer Res. 2016;36:5257-5263.
    >> Share

  98. ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
    Prognostic Significance of MicroRNA-21 Expression in Patients with Unresectable Metastatic Colon Cancer.
    Anticancer Res. 2016;36:5145-5151.
    >> Share

  99. SIDERIS M, Moorhead J, Diaz-Cano S, Bjarnason I, et al
    KRAS Mutant Status, p16 and beta-catenin Expression May Predict Local Recurrence in Patients Who Underwent Transanal Endoscopic Microsurgery (TEMS) for Stage I Rectal Cancer.
    Anticancer Res. 2016;36:5315-5324.
    >> Share

  100. ELZAGHEID A, Emaetig F, Elsaghayer W, Torjman F, et al
    Neurofibromin Expression is Associated with Aggressive Disease and Poor Outcome in Colorectal Carcinoma.
    Anticancer Res. 2016;36:5301-5306.
    >> Share

  101. BACZYNSKA D, Bombik I, Malicka-Blaszkiewicz M
    beta-Catenin Expression Regulates Cell Migration of Human Colonic Adenocarcinoma Cells Through Gelsolin.
    Anticancer Res. 2016;36:5249-5256.
    >> Share

  102. TAMPELLINI M, Benedetto S, Rubatto E, Baratelli C, et al
    Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions.
    Anticancer Res. 2016;36:5163-5170.
    >> Share

  103. DE FELICE F, Musio D, Benevento I, Magnante A, et al
    Influence of Organ Invasion in Clinical Outcomes for Locally Advanced Rectal Cancer.
    Anticancer Res. 2016;36:5443-5447.
    >> Share

  104. BISCANIN A, Ljubicic N, Boban M, Balicevic D, et al
    CX43 Expression in Colonic Adenomas and Surrounding Mucosa Is a Marker of Malignant Potential.
    Anticancer Res. 2016;36:5437-5442.
    >> Share

  105. NONAKA T, Fukuda A, Maekawa K, Nagayoshi S, et al
    Clinical and Oncological Outcomes of Laparoscopic Versus Open Surgery for Advanced Rectal Cancer.
    Anticancer Res. 2016;36:5419-5424.
    >> Share

  106. RUBIO CA, Schmidt PT
    Gut-associated Lymphoid Tissue (GALT) Carcinoma or Dome Carcinoma?
    Anticancer Res. 2016;36:5385-5387.
    >> Share

    September 2016
  107. KISS I, Mlcochova J, Bortlicek Z, Poprach A, et al
    Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients.
    Anticancer Res. 2016;36:4955-9.
    >> Share

  108. LIBERALE G, Vankerckhove S, Galdon MG, Larsimont D, et al
    Sentinel Lymph Node Detection by Blue Dye Versus Indocyanine Green Fluorescence Imaging in Colon Cancer.
    Anticancer Res. 2016;36:4853-8.
    >> Share

  109. PIKOULIS E, Margonis GA, Andreatos N, Sasaki K, et al
    Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases.
    Anticancer Res. 2016;36:4805-11.
    >> Share

  110. NAKANISHI M, Kuriu Y, Murayama Y, Arita T, et al
    Usefulness of Reduced Port Surgery for Left Colon Cancer.
    Anticancer Res. 2016;36:4749-52.
    >> Share

  111. KAWAGUCHI D, Hiroshima Y, Matsuo K, Endo I, et al
    Hepatic Resection After Prehepatectomy Chemotherapy for Metastatic Colorectal Cancer: A Propensity-Matched Analysis.
    Anticancer Res. 2016;36:4725-30.
    >> Share

  112. RACHAR V, Czejka M, Kitzmueller M, Buchner P, et al
    Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.
    Anticancer Res. 2016;36:4715-23.
    >> Share

  113. STANKEVICIUS V, Vasauskas G, Noreikiene R, Kuodyte K, et al
    Extracellular Matrix-dependent Pathways in Colorectal Cancer Cell Lines Reveal Potential Targets for Anticancer Therapies.
    Anticancer Res. 2016;36:4559-67.
    >> Share

  114. TANAKA R, Tomosugi M, Sakai T, Sowa Y, et al
    MEK Inhibitor Suppresses Expression of the miR-17-92 Cluster with G1-Phase Arrest in HT-29 Human Colon Cancer Cells and MIA PaCa-2 Pancreatic Cancer Cells.
    Anticancer Res. 2016;36:4537-43.
    >> Share

  115. LING E, Ringel A, Sigal-Batikoff I, Abu-Freha N, et al
    Human Colorectal Cancer Stage-dependent Global DNA Hypomethylation of Cancer-associated Fibroblasts.
    Anticancer Res. 2016;36:4503-7.
    >> Share

  116. YUN CW, Yun S, Lee JH, Han YS, et al
    Silencing Prion Protein in HT29 Human Colorectal Cancer Cells Enhances Anticancer Response to Fucoidan.
    Anticancer Res. 2016;36:4449-58.
    >> Share

  117. HOLUBEC L, Polivka J Jr, Safanda M, Karas M, et al
    The Role of Cetuximab in the Induction of Anticancer Immune Response in Colorectal Cancer Treatment.
    Anticancer Res. 2016;36:4421-6.
    >> Share

  118. DA SILVA FC, Wernhoff P, Dominguez-Barrera C, Dominguez-Valentin M, et al
    Update on Hereditary Colorectal Cancer.
    Anticancer Res. 2016;36:4399-405.
    >> Share

  119. SHIN YR, Kim KA, Im S, Hwang SS, et al
    Prediction of KRAS Mutation in Rectal Cancer Using MRI.
    Anticancer Res. 2016;36:4799-804.
    >> Share

  120. KAWAGUCHI D, Hiroshima Y, Matsuo K, Endo I, et al
    Parenchymal Congestion Is Important for Rapid Regeneration of the Future Liver Remnant Following the ALPPS Procedure.
    Anticancer Res. 2016;36:4731-8.
    >> Share

  121. ATANASOVA S, Nikolova B, Murayama S, Stoyanova E, et al
    Electroinduced Delivery of Hydrogel Nanoparticles in Colon 26 Cells, Visualized by Confocal Fluorescence System.
    Anticancer Res. 2016;36:4601-6.
    >> Share

  122. KAPPIL M, Terry MB, Delgado-Cruzata L, Liao Y, et al
    Mismatch Repair Polymorphisms as Markers of Breast Cancer Prevalence in the Breast Cancer Family Registry.
    Anticancer Res. 2016;36:4437-41.
    >> Share

    August 2016
  123. SUEDA T, Sakai D, Kudo T, Sugiura T, et al
    Efficacy and Safety of Regorafenib or TAS-102 in Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies.
    Anticancer Res. 2016;36:4299-306.
    >> Share

  124. MONTAGNANI F, DI Leonardo G, Pino MS, Martella F, et al
    Progression-free Survival as a Surrogate End-point in Advanced Colorectal Cancer Treated with Antiangiogenic Therapies.
    Anticancer Res. 2016;36:4259-65.
    >> Share

  125. PLOQUIN A, Zerimech F, Escande F, Adenis A, et al
    Lack of Relationship Between Clinical Features and KRAS Mutations in Patients with Metastatic Colorectal Cancer.
    Anticancer Res. 2016;36:4233-6.
    >> Share

  126. KUNIZAKI M, Sawai T, Takeshita H, Tominaga T, et al
    Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Anticancer Res. 2016;36:4171-5.
    >> Share

  127. BABA H, Ishikawa T, Mogushi K, Ishiguro M, et al
    Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
    Anticancer Res. 2016;36:4069-76.
    >> Share

  128. DJAAFAR S, Dunand-Sautier I, Gonelle-Gispert C, Lacotte S, et al
    Enoxaparin Attenuates Mouse Colon Cancer Liver Metastases by Inhibiting Heparanase and Interferon-gamma-inducible Chemokines.
    Anticancer Res. 2016;36:4019-32.
    >> Share

  129. ILHAN N, Gungor H, Gul HF, Eroksuz H, et al
    Expression of Endoglin and Vascular Endothelial Growth Factor as Prognostic Markers in Experimental Colorectal Cancer.
    Anticancer Res. 2016;36:3953-9.
    >> Share

  130. KUMASHIRO R, Konishi K, Chiba T, Akahoshi T, et al
    Integrated Endoscopic System Based on Optical Imaging and Hyperspectral Data Analysis for Colorectal Cancer Detection.
    Anticancer Res. 2016;36:3925-32.
    >> Share

  131. MEEKS MW, Grace S, Chen Y, Petterchak J, et al
    Synchronous Quadruple Primary Neoplasms: Colon Adenocarcinoma, Collision Tumor of Neuroendocrine Tumor and Schwann Cell Hamartoma and Sessile Serrated Adenoma of the Appendix.
    Anticancer Res. 2016;36:4307-11.
    >> Share

  132. ETO K, Kosuge M, Ohkuma M, Haruki K, et al
    Comparison of Transumbilical and Conventional Defunctioning Ileostomy in Laparoscopic Anterior Resections for Rectal Cancer.
    Anticancer Res. 2016;36:4139-44.
    >> Share

  133. PICARDI V, Deodato F, Guido A, Giaccherini L, et al
    Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study.
    Anticancer Res. 2016;36:4081-7.
    >> Share

    July 2016
  134. SHIRAIWA S, Kinugasa T, Kawahara A, Mizobe T, et al
    Nuclear Y-Box-binding Protein-1 Expression Predicts Poor Clinical Outcome in Stage III Colorectal Cancer.
    Anticancer Res. 2016;36:3781-8.
    >> Share

  135. YOSHIDA Y, Naito M, Yamada T, Aisu N, et al
    Adoptive Chemoimmunotherapy Using Activated alphabeta T Cells for Stage IV Colorectal Cancer.
    Anticancer Res. 2016;36:3741-6.
    >> Share

  136. MUKOHYAMA J, Shimono Y, Yamashita K, Sumi Y, et al
    Effect of Xenotransplantation Site on MicroRNA Expression of Human Colon Cancer Stem Cells.
    Anticancer Res. 2016;36:3679-86.
    >> Share

  137. YAMAGUCHI T, Iwasa S, Nagashima K, Ikezawa N, et al
    Comparison of Panitumumab Plus Irinotecan and Cetuximab Plus Irinotecan for KRAS Wild-type Metastatic Colorectal Cancer.
    Anticancer Res. 2016;36:3531-6.
    >> Share

  138. MATSUI T, Nagata N, Hirata K, Okazaki S, et al
    Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer -The PHOENiX Trial.
    Anticancer Res. 2016;36:3437-43.
    >> Share

  139. CHUNG YH, Kim D
    Enhanced TLR4 Expression on Colon Cancer Cells After Chemotherapy Promotes Cell Survival and Epithelial-Mesenchymal Transition Through Phosphorylation of GSK3beta.
    Anticancer Res. 2016;36:3383-94.
    >> Share

  140. KANG BW, Jeon HS, Chae YS, Lee SJ, et al
    Impact of Genetic Variation in MicroRNA-binding Site on Susceptibility to Colorectal Cancer.
    Anticancer Res. 2016;36:3353-61.
    >> Share

  141. YAMASAKI K, Matsui T, Hisabe T, Yano Y, et al
    Retrospective Analysis of Growth Speed of 54 Lesions of Colitis-associated Colorectal Neoplasia.
    Anticancer Res. 2016;36:3731-40.
    >> Share

  142. SAKAUE M, Maeda K, Ohno S, Ito T, et al
    Screening for Identification of Personalized Food to Promote Adiponectin Secretion in Patients with Cancer.
    Anticancer Res. 2016;36:3673-7.
    >> Share

  143. ALIBERTI C, Carandina R, Sarti D, Mulazzani L, et al
    Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.
    Anticancer Res. 2016;36:3515-21.
    >> Share

  144. AKINWANDE O, Scoggins C, Martin RC
    Early Experience with 70-150 mum Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
    Anticancer Res. 2016;36:3413-8.
    >> Share

    June 2016

  145. Laparoscopic Surgery for Colorectal Cancer.
    Anticancer Res. 2016;36:3225.
    >> Share

  146. BRADATSCH A, Kornprat P, Bacher H, Cerwenka H, et al
    The Value of Lymph Node Dissection in the Surgery of Colorectal Cancer Liver Metastases.
    Anticancer Res. 2016;36:2993-7.
    >> Share

  147. HENKENBERENS C, Toklu H, Tamme C, Bruns F, et al
    Clinical Value of Squamous Cell Carcinoma Antigen (SCCAg) in Anal Cancer - A Single-Center Retrospective Analysis.
    Anticancer Res. 2016;36:3173-7.
    >> Share

  148. MIYAMOTO J, Michaud AL, Harandi NK, Kim EJ, et al
    The Role of Image-guided Radiotherapy in the Treatment of Anorectal Cancer Using Prone Belly-board Positioning.
    Anticancer Res. 2016;36:3013-7.
    >> Share

  149. SODRING M, Gunnes G, Paulsen JE
    Detection and Characterization of Flat Aberrant Crypt Foci (Flat ACF) in the Novel A/J Min/+ Mouse.
    Anticancer Res. 2016;36:2745-50.
    >> Share

  150. NASIR A, Reising LO, Nedderman DM, Fulford AD, et al
    Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma.
    Anticancer Res. 2016;36:2683-96.
    >> Share

  151. HAO X, Xiao H, Ju J, Hewitt SM, et al
    Decreased Expression of Retinoid X Receptors During Human and Azoxymethane-induced Colorectal Carcinogenesis in the Rat.
    Anticancer Res. 2016;36:2659-64.
    >> Share

    May 2016
  152. SADAHIRO S, Suzuki T, Tanaka A, Okada K, et al
    Increase in Gene Expression of TYMP, DPYD and HIF1A Are Associated with Response to Preoperative Chemoradiotherapy Including S-1 or UFT for Rectal Cancer.
    Anticancer Res. 2016;36:2433-40.
    >> Share

  153. WISNIEWSKI J, Wesolowska O, Sroda-Pomianek K, Paprocka M, et al
    Euphorbia Species-derived Diterpenes and Coumarins as Multidrug Resistance Modulators in Human Colon Carcinoma Cells.
    Anticancer Res. 2016;36:2259-64.
    >> Share

  154. RADIC J, Kruslin B, Samija M, Ulamec M, et al
    Connexin 43 Expression in Primary Colorectal Carcinomas in Patients with Stage III and IV Disease.
    Anticancer Res. 2016;36:2189-96.
    >> Share

  155. YAMAUCHI K, Kokuryo T, Yokoyama Y, Uehara K, et al
    Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy.
    Anticancer Res. 2016;36:2175-9.
    >> Share

  156. TRESKA V
    Methods to Increase Future Liver Remnant Volume in Patients with Primarily Unresectable Colorectal Liver Metastases: Current State and Future Perspectives.
    Anticancer Res. 2016;36:2065-71.
    >> Share

    April 2016
  157. ABRAMS MJ, Koffer PP, Leonard KL
    The Emerging Non-operative Management of Non-metastatic Rectal Cancer: A Population Analysis.
    Anticancer Res. 2016;36:1699-702.
    >> Share

  158. KORBER MI, Staribacher A, Ratzenbock I, Steger G, et al
    NFkappaB-Associated Pathways in Progression of Chemoresistance to 5-Fluorouracil in an In Vitro Model of Colonic Carcinoma.
    Anticancer Res. 2016;36:1631-9.
    >> Share

  159. FRANCO P, Arcadipane F, Ragona R, Mistrangelo M, et al
    Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.
    Anticancer Res. 2016;36:2027-32.
    >> Share

  160. SUMRIEN H, Dadnam C, Hewitt J, McCarthy K, et al
    Feasibility of Transanal Minimally Invasive Surgery (TAMIS) for Rectal Tumours and Its Impact on Quality of Life - The Bristol Series.
    Anticancer Res. 2016;36:2005-9.
    >> Share

  161. TANAKAYA K, Yamaguchi T, Ishikawa H, Hinoi T, et al
    Causes of Cancer Death Among First-Degree Relatives in Japanese Families with Lynch Syndrome.
    Anticancer Res. 2016;36:1985-9.
    >> Share

  162. WINDRICHOVA J, Fuchsova R, Kucera R, Topolcan O, et al
    Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study.
    Anticancer Res. 2016;36:1973-8.
    >> Share

  163. FRANCO P, Arcadipane F, Ragona R, Mistrangelo M, et al
    Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.
    Anticancer Res. 2016;36:1943-8.
    >> Share

  164. NAKANISHI M, Kuriu Y, Murayama Y, Arita T, et al
    A Study on the Tolerability of Capecitabine plus Oxaliplatin as Adjuvant Chemotherapy.
    Anticancer Res. 2016;36:1851-4.
    >> Share

  165. ROMANO M, DE Francesco F, Zarantonello L, Ruffolo C, et al
    From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.
    Anticancer Res. 2016;36:1447-60.
    >> Share

    March 2016
  166. WU BO, Jiang WG, Zhou D, Cui YX, et al
    Knockdown of EPHA1 by CRISPR/CAS9 Promotes Adhesion and Motility of HRT18 Colorectal Carcinoma Cells.
    Anticancer Res. 2016;36:1211-9.
    >> Share

  167. HUANG Y, Alzahrani NA, Chua TC, Huo YR, et al
    Clinical Outcomes of Patients with Extensive Peritoneal Carcinomatosis Following Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.
    Anticancer Res. 2016;36:1033-40.
    >> Share

  168. ISHIKAWA T, Uetake H, Murotani K, Kobunai T, et al
    Genome-wide DNA Copy-number Analysis in ACTS-CC Trial of Adjuvant Chemotherapy for Stage III Colonic Cancer.
    Anticancer Res. 2016;36:853-60.
    >> Share

  169. HADAC JN, Miller DD, Grimes IC, Clipson L, et al
    Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance.
    Anticancer Res. 2016;36:845-52.
    >> Share

    February 2016
  170. KUCERA R, Topolcan O, Fiala O, Kinkorova J, et al
    The Role of TPS and TPA in the Diagnostics of Distant Metastases.
    Anticancer Res. 2016;36:773-7.
    >> Share

  171. JUNGINGER T, Goenner U, Hitzler M, Trinh TT, et al
    Influence of Local Recurrence and Distant Metastasis on Prognosis After Local Excision of Rectal Carcinoma.
    Anticancer Res. 2016;36:763-8.
    >> Share

  172. UEKI T, Manabe T, Inoue S, Ienaga J, et al
    A Feasibility Study of Neoadjuvant XELOX Without Radiotherapy for Locally Advanced Lower Rectal Cancer.
    Anticancer Res. 2016;36:741-7.
    >> Share

    January 2016
  173. KAWAHARA H, Misawa T, Watanabe K, Hojo S, et al
    Feasibility of Single-incision Laparoscopic Surgery plus One Assist Port for Anterior Resection.
    Anticancer Res. 2016;36:467-9.
    >> Share

  174. ZEZULOVA M, Bartouskova M, Hlidkova E, Juranova J, et al
    Prognostic Significance of Serum and Urinary Neopterin Concentrations in Patients with Rectal Carcinoma Treated with Chemoradiation.
    Anticancer Res. 2016;36:287-92.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016